| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/23/1994 | WO1994013302A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
| 06/23/1994 | WO1994013299A1 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis |
| 06/23/1994 | WO1994013298A1 Application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries |
| 06/23/1994 | WO1994013296A1 Application of lamotrigine in the treatment of neurological lesions related to traumatic injuries |
| 06/23/1994 | WO1994013288A1 Application of riluzole in the treatment of neurological lesions related to traumatic injuries |
| 06/23/1994 | WO1994013281A1 Anti-inflammatory and analgesic gel preparation |
| 06/23/1994 | WO1994013280A1 Sprayable analgesic composition and method of use |
| 06/23/1994 | WO1994013279A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same |
| 06/23/1994 | WO1994013271A1 System for dispensing pharmaceutically active compounds |
| 06/23/1994 | WO1994013270A1 Improving effectiveness of drugs |
| 06/23/1994 | WO1994013269A1 Smooth muscle chemical pacemaker |
| 06/23/1994 | WO1994013268A1 Method and device for treating and enlarging body lumens |
| 06/23/1994 | WO1994013267A1 Veterinary medicament |
| 06/23/1994 | WO1994013266A1 Novel electrostatic process for manufacturing coated transplants and products |
| 06/23/1994 | WO1994013265A1 A free radical quenching liposomal composition |
| 06/23/1994 | WO1994013263A1 Stabilized medicinal aerosol solution formulations |
| 06/23/1994 | WO1994013262A1 Stabilized medicinal aerosol solution formulations |
| 06/23/1994 | WO1994013261A1 Aqueous antibiotic composition for veterinary use |
| 06/23/1994 | WO1994013257A1 Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder |
| 06/23/1994 | WO1994013255A1 Antiperspirant-deodorant cosmetic stick products |
| 06/23/1994 | WO1994013252A1 Method for stimulating production of heme oxygenase using vitamin b12 |
| 06/23/1994 | WO1994013249A1 Encapsulation apparatus and process |
| 06/23/1994 | WO1994013235A1 Skin adhesive hydrogel, its preparation and uses |
| 06/23/1994 | WO1994008551A3 Pharmaceutical compositions and methods for treating cold symptoms |
| 06/23/1994 | DE4305553A1 Topical pharmaceutical or cosmetic compsn - contg. N-acyl-alkanolamine and phosphatidyl-ethanolamine derivs., e.g. for protecting skin against light or treating insect stings |
| 06/23/1994 | DE4305552A1 Topical pharmaceutical or cosmetic compsn - contg N-acyl-alkanolamine, used for e.g. protecting skin against light or treating insect bites |
| 06/23/1994 | CA2151603A1 Application of anticonvulsant in the treatment of neurological lesions associated with traumas |
| 06/23/1994 | CA2151601A1 Application of lamotrigin in the treatment of neurological lesions associated with traumas |
| 06/23/1994 | CA2151495A1 A free radical quenching liposomal composition |
| 06/23/1994 | CA2151148A1 Method for stimulating production of heme oxygenase using vitamin b12 |
| 06/23/1994 | CA2151055A1 Smooth muscle chemical pacemaker |
| 06/23/1994 | CA2150383A1 Antacid composition and method of production |
| 06/23/1994 | CA2150033A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
| 06/23/1994 | CA2149754A1 Lipid prodrugs for oral administration |
| 06/23/1994 | CA2129744A1 Skin adhesive hydrogel, its preparation and uses |
| 06/23/1994 | CA2111455A1 Multilayered biodegradable stent and method for its manufacture |
| 06/23/1994 | CA2110939A1 An innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 06/22/1994 | EP0603160A2 Compositions for in-situ active compound assembly |
| 06/22/1994 | EP0603159A2 Human growth hormone formulation |
| 06/22/1994 | EP0602921A1 Bicarbonate dialysis dialysate component and method of manufacture |
| 06/22/1994 | EP0602702A1 The use of tyloxapol as a nanoparticle stabilizer and dispersant |
| 06/22/1994 | EP0602619A1 Controlled-release pharmaceutical compositions containing nicergoline |
| 06/22/1994 | EP0602586A2 Stable pharmaceutical composition of fumagillol derivatives |
| 06/22/1994 | EP0602543A1 Layered carrier for the diagnosis and therapy of sicknesses and use thereof |
| 06/22/1994 | EP0602513A2 Microcapsule with a core suitable as levelling agent |
| 06/22/1994 | EP0602280A1 Stabilized caloric nutritive solution and Multiple chambers device for the parenteral nutrition of man |
| 06/22/1994 | EP0602181A1 Medicinal aerosol formulations |
| 06/22/1994 | EP0602112A1 High content ibuprofen agglomerates and process to prepare them |
| 06/22/1994 | EP0526531B1 Liposomes with positive excess charge |
| 06/22/1994 | EP0437479B1 Method of making liposomes with improved stability during drying |
| 06/22/1994 | EP0424534B1 Pharmaceutical preparation for treatment of mastitis in animals and humans |
| 06/22/1994 | CN1088205A Improvements in or relating to benzothiophenes |
| 06/22/1994 | CN1088104A Blood pressure lowing plaster and its preparation |
| 06/22/1994 | CN1088098A Method for preparing active blood products from tortoise and/or soft-shelled turtle |
| 06/22/1994 | CN1088092A Microparticle preparation and production thereof |
| 06/22/1994 | CN1088091A Programmed release tablets containing naproxen |
| 06/22/1994 | CN1025105C Method of making anticarious tooth chewing gum |
| 06/21/1994 | US5322925 First block has lactide as predominant component; second has trimethyl carbonate in predominance |
| 06/21/1994 | US5322698 Homogenizing with anhydrous alkaline earth metal salt and microcrystalline cellulose, compressing |
| 06/21/1994 | US5322697 Composition and method for inducing satiety |
| 06/21/1994 | US5322696 Flavoring, fragrance, skin texturizing and deodorant materials and method of making same |
| 06/21/1994 | US5322695 Moisture-vapor-permeable dressing |
| 06/21/1994 | US5322694 Pharmaceutical lozenges |
| 06/21/1994 | US5322693 Lactoneotrehalose, and its preparation and uses |
| 06/21/1994 | US5322692 Containing LLF28249 or derivative, glycerol monostearate, carnauba wax, barium sulfate |
| 06/21/1994 | US5322691 Flexible body; sustained release by diffusion, osmosis or bioerosion |
| 06/21/1994 | US5322689 Copolymer of acrylic acid and fatty alcohol acrylate ester crosslinked with polyalkenyl polyether of polyhydric alcohol, volatile aromatic compound |
| 06/21/1994 | US5322685 Skin cream preparation for external use |
| 06/21/1994 | US5322683 Foamable topically absorbable anhydrous liquid, foaming agent, propellant |
| 06/21/1994 | CA2002343C Tailored beta-prime stable triglyceride hardstock |
| 06/21/1994 | CA1330304C Tissue irrigating solution |
| 06/21/1994 | CA1330301C Stabilised human protein preparations |
| 06/21/1994 | CA1330300C Pharmaceutical preparation for therapy of immunodeficit states |
| 06/21/1994 | CA1330297C Aqueous solution of fat-soluble substance |
| 06/19/1994 | CA2099093A1 Organic envelopment |
| 06/17/1994 | CA2111560A1 Stable pharmaceutical composition of fumagillol derivatives |
| 06/17/1994 | CA2102356A1 Use of purified surface modifiers to prevent particle aggregation during sterilization |
| 06/16/1994 | DE4308406C1 Contraceptive compsn. with reduced hormone dose and reduced side-effects - contg. synergistic mixt. of biogenic, synthetic oestrogen and gestagen |
| 06/16/1994 | DE4241874A1 Medizinisches Pflaster für die perkutane Verabreichung Medical patch for percutaneous administration |
| 06/15/1994 | EP0601965A2 Process for making shearform matrix |
| 06/15/1994 | EP0601908A1 Process for obtaining a swalloable, suckable, crunchable dilutable compressed medicine |
| 06/15/1994 | EP0601891A1 Antifungal and skin healing promoting agent |
| 06/15/1994 | EP0601835A1 Pharmaceutical product |
| 06/15/1994 | EP0601799A1 Sustained-release preparation |
| 06/15/1994 | EP0601619A2 Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| 06/15/1994 | EP0601618A2 Use of charged phospholipids for decreasing nanoparticulate aggregation |
| 06/15/1994 | EP0601508A2 Liquid-suspension controlled-release pharmaceutical composition |
| 06/15/1994 | EP0601058A1 Transdermal formulations for administering prazosin |
| 06/15/1994 | EP0601053A1 Compositions and methods for the sublingual or buccal administration of therapeutic agents |
| 06/15/1994 | EP0600973A1 A method for treatment of metabolic disorders and metabolism |
| 06/15/1994 | EP0600959A1 Emulsions of polar oils in water |
| 06/15/1994 | CN1087822A Prescription of "Xiangkening" acupuncture point plaster for treatment of cough and its production method |
| 06/15/1994 | CN1087792A Vitamin garlic capsule and its making method |
| 06/15/1994 | CN1025035C Prepn. of cross-linked esters of hyaluronic acid |
| 06/14/1994 | US5321022 Mixture of emedastine (a diazepiny/benzimidazole derivative) and aliphatic mono- and di-alkyl esters |
| 06/14/1994 | US5321014 Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells |
| 06/14/1994 | US5321013 Pharmaceutical compositions in the form of stable sucralfate suspensions free of suspending agents |
| 06/14/1994 | US5320906 Delivery vehicles with amphiphile-associated active ingredient |
| 06/14/1994 | US5320863 Transparent oil-in-water microemulsion flavor concentrate |
| 06/14/1994 | US5320855 Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |